Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Maiheng Pharmaceutical R&D is a specialized Contract Research Organization (CRO) based in Guangzhou, China, focusing on small molecule drug discovery and chemical development. The company offers a broad range of services including medicinal chemistry, custom synthesis, and process chemistry (CMC) to support pharmaceutical and biotechnology clients. Their technical expertise extends to the synthesis of complex intermediates, reference compounds, and drug impurities required for regulatory filings. By leveraging advanced analytical platforms and a team of experienced chemists, Maiheng Pharma facilitates the transition of drug candidates from discovery to clinical development. The firm is committed to providing high-quality, cost-effective R&D solutions to accelerate the global drug innovation process.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 广东迈恒医药研发.